FDA approves boceprevir to treat hepatitis C. PDF Print
Washington Post: The Food and Drug Administration on Friday approved a highly anticipated hepatitis C drug from Merck that is the first new treatment for the virus in 20 years. The first-of-its-kind pill, Victrelis, has been shown to cure more patients in less time than the older drugs now used.

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.